Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polysaccharide superparamagnetic iron oxide refers to nanoparticles composed of an iron oxide core exhibiting superparamagnetism and coated with a natural or synthetic polysaccharide layer. These particles are engineered for biomedical applications such as drug delivery, magnetic resonance imaging (MRI) contrast enhancement, and targeted therapy. The polysaccharide coating improves biocompatibility, stability in biological fluids, and allows for further functionalization with drugs or targeting ligands. Mechanistically, these nanoparticles can be directed by external magnetic fields to specific tissues or tumors for localized drug delivery or imaging. They are also being explored as carriers for nucleic acids like mRNA in gene therapy research[1][2][3][4][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Polysaccharide superparamagnetic iron oxide.